| Mrs Barbara Kay Jefferson, PHD | |
|
611 Forest Avenue, Maysville, KY 41056 | |
| (606) 564-4016 | |
| (606) 564-8288 |
| Full Name | Mrs Barbara Kay Jefferson |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Counseling |
| Location | 611 Forest Avenue, Maysville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407801020 | NPI | - | NPPES |
| 30608012 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | 929 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Barbara Kay Jefferson, PHD 611 Forest Avenue, Maysville, KY 41056 Ph: (606) 564-4016 | Mrs Barbara Kay Jefferson, PHD 611 Forest Avenue, Maysville, KY 41056 Ph: (606) 564-4016 |
News Archive
Researchers at the Stanford University School of Medicine have illuminated the path taken by human neural stem cells that were transplanted into the brains of rats and mice, and found that the cells successfully navigate toward areas damaged by stroke.
A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today that A-Life Hospital, its wholly owned subsidiary, introduced a new distributor program, A-Life Partners.
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.
Sepsis is the name of an infection that causes a series of reactions in the body, which in the worst case can prove fatal. The problem for both patients and doctors is that the early symptoms are difficult to distinguish from less dangerous infections such as a severe flu or winter vomiting disease.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
› Verified 5 days ago
Jarvis M Brookins, LPCA Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s. 68 Ste 900, Maysville, KY 41056 Phone: 606-584-7055 | |
Nancy Jeanne Vanzile, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016 Fax: 606-564-4016 | |
Jeffrey A Drury, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016 Fax: 606-564-8288 | |
Janice W George, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016 Fax: 606-564-8288 | |
Megan Howell, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016 Fax: 606-564-8288 | |
Dr. Phyllis Raye Biddle, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016 Fax: 606-564-0295 |